市場調査レポート
商品コード
1457296

セラノスティクスの世界市場規模、シェア、動向分析レポート:エンドユーザー別、製品別、用途別、地域別展望と予測、2023~2030年

Global Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023 - 2030

出版日: | 発行: KBV Research | ページ情報: 英文 239 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
セラノスティクスの世界市場規模、シェア、動向分析レポート:エンドユーザー別、製品別、用途別、地域別展望と予測、2023~2030年
出版日: 2024年03月14日
発行: KBV Research
ページ情報: 英文 239 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のセラノスティクスの市場規模は、予測期間中に15.2%のCAGRで市場成長し、2030年までに54億米ドルに達すると予想されています。

さらに、放射性医薬品は診断用画像診断と標的治療の両方の機能を備えているため、セラノスティクス用途に最適です。放射性医薬品は、診断用画像診断(例:陽電子放出断層撮影法または単光子放出コンピューター断層撮影法)用のガンマ線を放出する放射性同位元素と、治療目的(例:放射免疫療法または標的放射性核種療法)用のベータ粒子で標識できます。したがって、放射性医薬品の急速な成長が市場の成長を牽引しています。

しかし、セラノスティクスアプローチには、分子診断、画像診断法、標的療法、ドラッグデリバリーシステムなどの高度な技術の統合が含まれることがよくあります。これらの技術の開発と実装には、生物学、化学、物理学、工学など、複数の分野の専門知識が必要です。したがって、技術的な複雑さが市場の成長を妨げています。

パンデミックの初期段階では、ヘルスケア資源と優先事項は、COVID-19の拡散の管理と制御へとシフトしました。診断画像や個別化医療の取り組みなど、緊急を要しない医療処置から資源と焦点が転用されたことで、臨床現場でのセラノスティクス技術の採用と実装が一時的に遅れました。また、COVID-19パンデミックは世界のサプライチェーンを混乱させ、セラノスティクス製品、部品、原材料の入手可能性と流通に影響を与えました。そのため、COVID-19パンデミックは市場に悪影響を及ぼしました。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場要覧

  • 主要なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主要な要因
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 市場の課題
  • ポーターのファイブフォース分析

第4章 世界市場:エンドユーザー別

  • 世界の病院・がん治療センター市場:地域別
  • 世界のセラノスティクスセンター市場:地域別
  • 世界の研究・学術センター市場:地域別

第5章 世界市場:製品別

  • 世界の放射性医薬品市場:地域別
  • 世界の診断用画像市場:地域別
  • 世界のIVD/バイオマーカースクリーニング市場:地域別
  • 世界のソフトウェア・サービス市場:地域別

第6章 世界市場:用途別

  • 世界の前立腺がん市場:地域別
  • 世界の骨転移市場:地域別
  • 世界のその他のがん市場:地域別
  • 世界のその他の市場:地域別

第7章 世界市場:地域別

  • 北米
    • 北米の市場:国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場:国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場:国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場:国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第8章 企業プロファイル

  • Bayer AG
  • GE HealthCare Technologies, Inc
  • Siemens Healthineers AG(Siemens AG)
  • Cardinal Health, Inc
  • Canon, Inc
  • Clarity Pharmaceuticals Ltd
  • Koninklijke Philips NV
  • Thermo Fisher Scientific, Inc
  • Telix Pharmaceuticals Limited
  • ABX advanced biochemical compounds GmbH

第9章 セラノスティクス市場の成功必須条件

図表

LIST OF TABLES

  • TABLE 1Global Theranostics Market, 2019 - 2022, USD Million
  • TABLE 2Global Theranostics Market, 2023 - 2030, USD Million
  • TABLE 3Global Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 4Global Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 5Global Hospitals & Cancer Care Centers Market by Region, 2019 - 2022, USD Million
  • TABLE 6Global Hospitals & Cancer Care Centers Market by Region, 2023 - 2030, USD Million
  • TABLE 7Global Theranostics Centers Market by Region, 2019 - 2022, USD Million
  • TABLE 8Global Theranostics Centers Market by Region, 2023 - 2030, USD Million
  • TABLE 9Global Research & Academic Centers Market by Region, 2019 - 2022, USD Million
  • TABLE 10Global Research & Academic Centers Market by Region, 2023 - 2030, USD Million
  • TABLE 11Global Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 12Global Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 13Global Radiopharmaceuticals Market by Region, 2019 - 2022, USD Million
  • TABLE 14Global Radiopharmaceuticals Market by Region, 2023 - 2030, USD Million
  • TABLE 15Global Diagnostic Imaging Market by Region, 2019 - 2022, USD Million
  • TABLE 16Global Diagnostic Imaging Market by Region, 2023 - 2030, USD Million
  • TABLE 17Global IVD/Biomarker Screening Market by Region, 2019 - 2022, USD Million
  • TABLE 18Global IVD/Biomarker Screening Market by Region, 2023 - 2030, USD Million
  • TABLE 19Global Software & Services Market by Region, 2019 - 2022, USD Million
  • TABLE 20Global Software & Services Market by Region, 2023 - 2030, USD Million
  • TABLE 21Global Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 22Global Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 23Global Prostate Cancer Market by Region, 2019 - 2022, USD Million
  • TABLE 24Global Prostate Cancer Market by Region, 2023 - 2030, USD Million
  • TABLE 25Global Bone Metastasis Market by Region, 2019 - 2022, USD Million
  • TABLE 26Global Bone Metastasis Market by Region, 2023 - 2030, USD Million
  • TABLE 27Global Other Cancers Market by Region, 2019 - 2022, USD Million
  • TABLE 28Global Other Cancers Market by Region, 2023 - 2030, USD Million
  • TABLE 29Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 30Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 31Global Theranostics Market by Region, 2019 - 2022, USD Million
  • TABLE 32Global Theranostics Market by Region, 2023 - 2030, USD Million
  • TABLE 33North America Theranostics Market, 2019 - 2022, USD Million
  • TABLE 34North America Theranostics Market, 2023 - 2030, USD Million
  • TABLE 35North America Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 36North America Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 37North America Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 38North America Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 39North America Theranostics Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 40North America Theranostics Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 41North America Research & Academic Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 42North America Research & Academic Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 43North America Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 44North America Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 45North America Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
  • TABLE 46North America Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
  • TABLE 47North America Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
  • TABLE 48North America Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
  • TABLE 49North America IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
  • TABLE 50North America IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
  • TABLE 51North America Software & Services Market by Country, 2019 - 2022, USD Million
  • TABLE 52North America Software & Services Market by Country, 2023 - 2030, USD Million
  • TABLE 53North America Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 54North America Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 55North America Prostate Cancer Market by Country, 2019 - 2022, USD Million
  • TABLE 56North America Prostate Cancer Market by Country, 2023 - 2030, USD Million
  • TABLE 57North America Bone Metastasis Market by Country, 2019 - 2022, USD Million
  • TABLE 58North America Bone Metastasis Market by Country, 2023 - 2030, USD Million
  • TABLE 59North America Other Cancers Market by Country, 2019 - 2022, USD Million
  • TABLE 60North America Other Cancers Market by Country, 2023 - 2030, USD Million
  • TABLE 61North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 62North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 63North America Theranostics Market by Country, 2019 - 2022, USD Million
  • TABLE 64North America Theranostics Market by Country, 2023 - 2030, USD Million
  • TABLE 65US Theranostics Market, 2019 - 2022, USD Million
  • TABLE 66US Theranostics Market, 2023 - 2030, USD Million
  • TABLE 67US Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 68US Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 69US Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 70US Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 71US Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 72US Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 73Canada Theranostics Market, 2019 - 2022, USD Million
  • TABLE 74Canada Theranostics Market, 2023 - 2030, USD Million
  • TABLE 75Canada Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 76Canada Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 77Canada Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 78Canada Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 79Canada Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 80Canada Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 81Mexico Theranostics Market, 2019 - 2022, USD Million
  • TABLE 82Mexico Theranostics Market, 2023 - 2030, USD Million
  • TABLE 83Mexico Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 84Mexico Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 85Mexico Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 86Mexico Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 87Mexico Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 88Mexico Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 89Rest of North America Theranostics Market, 2019 - 2022, USD Million
  • TABLE 90Rest of North America Theranostics Market, 2023 - 2030, USD Million
  • TABLE 91Rest of North America Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 92Rest of North America Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 93Rest of North America Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 94Rest of North America Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 95Rest of North America Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 96Rest of North America Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 97Europe Theranostics Market, 2019 - 2022, USD Million
  • TABLE 98Europe Theranostics Market, 2023 - 2030, USD Million
  • TABLE 99Europe Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 100Europe Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 101Europe Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 102Europe Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 103Europe Theranostics Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 104Europe Theranostics Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 105Europe Research & Academic Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 106Europe Research & Academic Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 107Europe Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 108Europe Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 109Europe Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
  • TABLE 110Europe Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
  • TABLE 111Europe Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
  • TABLE 112Europe Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
  • TABLE 113Europe IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
  • TABLE 114Europe IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
  • TABLE 115Europe Software & Services Market by Country, 2019 - 2022, USD Million
  • TABLE 116Europe Software & Services Market by Country, 2023 - 2030, USD Million
  • TABLE 117Europe Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 118Europe Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 119Europe Prostate Cancer Market by Country, 2019 - 2022, USD Million
  • TABLE 120Europe Prostate Cancer Market by Country, 2023 - 2030, USD Million
  • TABLE 121Europe Bone Metastasis Market by Country, 2019 - 2022, USD Million
  • TABLE 122Europe Bone Metastasis Market by Country, 2023 - 2030, USD Million
  • TABLE 123Europe Other Cancers Market by Country, 2019 - 2022, USD Million
  • TABLE 124Europe Other Cancers Market by Country, 2023 - 2030, USD Million
  • TABLE 125Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 126Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 127Europe Theranostics Market by Country, 2019 - 2022, USD Million
  • TABLE 128Europe Theranostics Market by Country, 2023 - 2030, USD Million
  • TABLE 129Germany Theranostics Market, 2019 - 2022, USD Million
  • TABLE 130Germany Theranostics Market, 2023 - 2030, USD Million
  • TABLE 131Germany Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 132Germany Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 133Germany Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 134Germany Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 135Germany Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 136Germany Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 137UK Theranostics Market, 2019 - 2022, USD Million
  • TABLE 138UK Theranostics Market, 2023 - 2030, USD Million
  • TABLE 139UK Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 140UK Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 141UK Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 142UK Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 143UK Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 144UK Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 145France Theranostics Market, 2019 - 2022, USD Million
  • TABLE 146France Theranostics Market, 2023 - 2030, USD Million
  • TABLE 147France Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 148France Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 149France Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 150France Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 151France Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 152France Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 153Russia Theranostics Market, 2019 - 2022, USD Million
  • TABLE 154Russia Theranostics Market, 2023 - 2030, USD Million
  • TABLE 155Russia Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 156Russia Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 157Russia Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 158Russia Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 159Russia Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 160Russia Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 161Spain Theranostics Market, 2019 - 2022, USD Million
  • TABLE 162Spain Theranostics Market, 2023 - 2030, USD Million
  • TABLE 163Spain Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 164Spain Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 165Spain Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 166Spain Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 167Spain Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 168Spain Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 169Italy Theranostics Market, 2019 - 2022, USD Million
  • TABLE 170Italy Theranostics Market, 2023 - 2030, USD Million
  • TABLE 171Italy Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 172Italy Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 173Italy Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 174Italy Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 175Italy Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 176Italy Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 177Rest of Europe Theranostics Market, 2019 - 2022, USD Million
  • TABLE 178Rest of Europe Theranostics Market, 2023 - 2030, USD Million
  • TABLE 179Rest of Europe Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 180Rest of Europe Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 181Rest of Europe Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 182Rest of Europe Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 183Rest of Europe Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 184Rest of Europe Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 185Asia Pacific Theranostics Market, 2019 - 2022, USD Million
  • TABLE 186Asia Pacific Theranostics Market, 2023 - 2030, USD Million
  • TABLE 187Asia Pacific Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 188Asia Pacific Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 189Asia Pacific Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 190Asia Pacific Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 191Asia Pacific Theranostics Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 192Asia Pacific Theranostics Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 193Asia Pacific Research & Academic Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 194Asia Pacific Research & Academic Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 195Asia Pacific Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 196Asia Pacific Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 197Asia Pacific Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
  • TABLE 198Asia Pacific Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
  • TABLE 199Asia Pacific Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
  • TABLE 200Asia Pacific Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
  • TABLE 201Asia Pacific IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
  • TABLE 202Asia Pacific IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
  • TABLE 203Asia Pacific Software & Services Market by Country, 2019 - 2022, USD Million
  • TABLE 204Asia Pacific Software & Services Market by Country, 2023 - 2030, USD Million
  • TABLE 205Asia Pacific Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 206Asia Pacific Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 207Asia Pacific Prostate Cancer Market by Country, 2019 - 2022, USD Million
  • TABLE 208Asia Pacific Prostate Cancer Market by Country, 2023 - 2030, USD Million
  • TABLE 209Asia Pacific Bone Metastasis Market by Country, 2019 - 2022, USD Million
  • TABLE 210Asia Pacific Bone Metastasis Market by Country, 2023 - 2030, USD Million
  • TABLE 211Asia Pacific Other Cancers Market by Country, 2019 - 2022, USD Million
  • TABLE 212Asia Pacific Other Cancers Market by Country, 2023 - 2030, USD Million
  • TABLE 213Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 214Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 215Asia Pacific Theranostics Market by Country, 2019 - 2022, USD Million
  • TABLE 216Asia Pacific Theranostics Market by Country, 2023 - 2030, USD Million
  • TABLE 217China Theranostics Market, 2019 - 2022, USD Million
  • TABLE 218China Theranostics Market, 2023 - 2030, USD Million
  • TABLE 219China Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 220China Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 221China Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 222China Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 223China Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 224China Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 225Japan Theranostics Market, 2019 - 2022, USD Million
  • TABLE 226Japan Theranostics Market, 2023 - 2030, USD Million
  • TABLE 227Japan Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 228Japan Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 229Japan Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 230Japan Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 231Japan Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 232Japan Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 233India Theranostics Market, 2019 - 2022, USD Million
  • TABLE 234India Theranostics Market, 2023 - 2030, USD Million
  • TABLE 235India Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 236India Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 237India Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 238India Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 239India Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 240India Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 241South Korea Theranostics Market, 2019 - 2022, USD Million
  • TABLE 242South Korea Theranostics Market, 2023 - 2030, USD Million
  • TABLE 243South Korea Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 244South Korea Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 245South Korea Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 246South Korea Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 247South Korea Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 248South Korea Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 249Singapore Theranostics Market, 2019 - 2022, USD Million
  • TABLE 250Singapore Theranostics Market, 2023 - 2030, USD Million
  • TABLE 251Singapore Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 252Singapore Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 253Singapore Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 254Singapore Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 255Singapore Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 256Singapore Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 257Malaysia Theranostics Market, 2019 - 2022, USD Million
  • TABLE 258Malaysia Theranostics Market, 2023 - 2030, USD Million
  • TABLE 259Malaysia Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 260Malaysia Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 261Malaysia Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 262Malaysia Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 263Malaysia Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 264Malaysia Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 265Rest of Asia Pacific Theranostics Market, 2019 - 2022, USD Million
  • TABLE 266Rest of Asia Pacific Theranostics Market, 2023 - 2030, USD Million
  • TABLE 267Rest of Asia Pacific Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 268Rest of Asia Pacific Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 269Rest of Asia Pacific Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 270Rest of Asia Pacific Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 271Rest of Asia Pacific Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 272Rest of Asia Pacific Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 273LAMEA Theranostics Market, 2019 - 2022, USD Million
  • TABLE 274LAMEA Theranostics Market, 2023 - 2030, USD Million
  • TABLE 275LAMEA Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 276LAMEA Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 277LAMEA Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 278LAMEA Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 279LAMEA Theranostics Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 280LAMEA Theranostics Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 281LAMEA Research & Academic Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 282LAMEA Research & Academic Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 283LAMEA Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 284LAMEA Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 285LAMEA Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
  • TABLE 286LAMEA Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
  • TABLE 287LAMEA Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
  • TABLE 288LAMEA Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
  • TABLE 289LAMEA IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
  • TABLE 290LAMEA IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
  • TABLE 291LAMEA Software & Services Market by Country, 2019 - 2022, USD Million
  • TABLE 292LAMEA Software & Services Market by Country, 2023 - 2030, USD Million
  • TABLE 293LAMEA Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 294LAMEA Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 295LAMEA Prostate Cancer Market by Country, 2019 - 2022, USD Million
  • TABLE 296LAMEA Prostate Cancer Market by Country, 2023 - 2030, USD Million
  • TABLE 297LAMEA Bone Metastasis Market by Country, 2019 - 2022, USD Million
  • TABLE 298LAMEA Bone Metastasis Market by Country, 2023 - 2030, USD Million
  • TABLE 299LAMEA Other Cancers Market by Country, 2019 - 2022, USD Million
  • TABLE 300LAMEA Other Cancers Market by Country, 2023 - 2030, USD Million
  • TABLE 301LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 302LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 303LAMEA Theranostics Market by Country, 2019 - 2022, USD Million
  • TABLE 304LAMEA Theranostics Market by Country, 2023 - 2030, USD Million
  • TABLE 305Brazil Theranostics Market, 2019 - 2022, USD Million
  • TABLE 306Brazil Theranostics Market, 2023 - 2030, USD Million
  • TABLE 307Brazil Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 308Brazil Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 309Brazil Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 310Brazil Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 311Brazil Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 312Brazil Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 313Argentina Theranostics Market, 2019 - 2022, USD Million
  • TABLE 314Argentina Theranostics Market, 2023 - 2030, USD Million
  • TABLE 315Argentina Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 316Argentina Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 317Argentina Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 318Argentina Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 319Argentina Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 320Argentina Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 321UAE Theranostics Market, 2019 - 2022, USD Million
  • TABLE 322UAE Theranostics Market, 2023 - 2030, USD Million
  • TABLE 323UAE Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 324UAE Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 325UAE Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 326UAE Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 327UAE Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 328UAE Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 329Saudi Arabia Theranostics Market, 2019 - 2022, USD Million
  • TABLE 330Saudi Arabia Theranostics Market, 2023 - 2030, USD Million
  • TABLE 331Saudi Arabia Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 332Saudi Arabia Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 333Saudi Arabia Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 334Saudi Arabia Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 335Saudi Arabia Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 336Saudi Arabia Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 337South Africa Theranostics Market, 2019 - 2022, USD Million
  • TABLE 338South Africa Theranostics Market, 2023 - 2030, USD Million
  • TABLE 339South Africa Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 340South Africa Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 341South Africa Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 342South Africa Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 343South Africa Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 344South Africa Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 345Nigeria Theranostics Market, 2019 - 2022, USD Million
  • TABLE 346Nigeria Theranostics Market, 2023 - 2030, USD Million
  • TABLE 347Nigeria Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 348Nigeria Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 349Nigeria Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 350Nigeria Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 351Nigeria Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 352Nigeria Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 353Rest of LAMEA Theranostics Market, 2019 - 2022, USD Million
  • TABLE 354Rest of LAMEA Theranostics Market, 2023 - 2030, USD Million
  • TABLE 355Rest of LAMEA Theranostics Market by End User, 2019 - 2022, USD Million
  • TABLE 356Rest of LAMEA Theranostics Market by End User, 2023 - 2030, USD Million
  • TABLE 357Rest of LAMEA Theranostics Market by Product, 2019 - 2022, USD Million
  • TABLE 358Rest of LAMEA Theranostics Market by Product, 2023 - 2030, USD Million
  • TABLE 359Rest of LAMEA Theranostics Market by Application, 2019 - 2022, USD Million
  • TABLE 360Rest of LAMEA Theranostics Market by Application, 2023 - 2030, USD Million
  • TABLE 361Key Information - Bayer AG
  • TABLE 362Key Information - GE HealthCare Technologies, Inc.
  • TABLE 363Key Information - Siemens Healthineers AG
  • TABLE 364key information - Cardinal Health, Inc.
  • TABLE 365Key Information - Canon, Inc.
  • TABLE 366Key Information - Clarity Pharmaceuticals Ltd
  • TABLE 367Key Information - Koninklijke Philips N.V.
  • TABLE 368Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 369Key Information - Telix Pharmaceuticals Limited
  • TABLE 370Key Information - ABX advanced biochemical compounds GmbH
目次

The Global Theranostics Market size is expected to reach $5.4 billion by 2030, rising at a market growth of 15.2% CAGR during the forecast period.

North America boasts a well-developed healthcare infrastructure with modern hospitals, diagnostic centers, and research institutions with state-of-the-art medical technologies. Therefore, the North America region captured $782.9 million revenue in the market in 2022. The availability of advanced diagnostic imaging modalities, molecular diagnostic laboratories, and therapeutic facilities enables the adoption and integration of theranostic approaches into clinical practice.

Targeted therapies align with the principles of precision medicine, which emphasize the customization of healthcare interventions based on individual patient characteristics, including genetic makeup, biomarker expression profiles, and disease phenotypes. Targeting specific molecular alterations or disease pathways, targeted therapies offer personalized treatment strategies tailored to individual patient's unique genetic and molecular profiles. Therefore, innovation in targeted therapies is propelling the growth of the market.

Additionally, radiopharmaceuticals possess dual capabilities for diagnostic imaging and targeted therapy, making them ideal candidates for theranostic applications. Radiopharmaceuticals can be labeled with radioactive isotopes that emit gamma rays for diagnostic imaging (e.g., positron emission tomography or single-photon emission computed tomography) and beta particles for therapeutic purposes (e.g., radioimmunotherapy or targeted radionuclide therapy). Hence, rapid growth in radiopharmaceuticals is driving the growth of the market.

However, theranostic approaches often involve integrating sophisticated technologies, including molecular diagnostics, imaging modalities, targeted therapies, and drug delivery systems. Developing and implementing these technologies require specialized expertise in multiple disciplines, such as biology, chemistry, physics, and engineering. Hence, technical complexity hampers the growth of the market.

During the initial stages of the pandemic, healthcare resources and priorities shifted towards managing and controlling the spread of COVID-19. This diversion of resources and focus away from non-urgent medical procedures, including diagnostic imaging and personalized medicine initiatives, temporarily slowed the adoption and implementation of theranostic technologies in clinical practice. Also, the COVID-19 pandemic disrupted global supply chains, affecting the availability and distribution of theranostic products, components, and raw materials. Therefore, the COVID-19 pandemic had a negative impact on the market.

By End User Analysis

Based on end user, the market is categorized into hospitals & cancer care centers, theranostics centers, and research & academic centers. In 2022, the hospitals & cancer care centers segment registered 50.3% revenue share in the market. Hospitals and cancer care centers serve as hubs for comprehensive healthcare services, offering various diagnostic, therapeutic, and supportive care options for patients with complex medical conditions like cancer.

By Product Analysis

Based on product, the market is divided into diagnostic imaging, radiopharmaceuticals, IVD/biomarker screening, and software & services. In 2022, the diagnostic imaging segment garnered 30.5% revenue share in the market. Diagnostic imaging provides valuable treatment planning and guidance information by visualizing disease extent, localization, and staging.

By Application Analysis

On the basis of application, the market is segmented into prostate cancer, bone metastasis, other cancers, and others. The prostate cancer segment recorded 38.1% revenue share in the market in 2022. Prostate cancer exhibits significant heterogeneity in terms of disease aggressiveness, treatment response, and patient outcomes. Theranostic approaches allow for personalizing treatment strategies based on individual patient characteristics and tumor biology.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region generated 23.0% revenue share in the market. The Asia Pacific region is experiencing a rising burden of chronic diseases, including cancer, cardiovascular diseases, and metabolic disorders, due to aging populations, urbanization, and changing lifestyles.

List of Key Companies Profiled

  • Bayer AG
  • GE HealthCare Technologies, Inc.
  • Siemens Healthineers AG (Siemens AG)
  • Cardinal Health, Inc.
  • Canon, Inc.
  • Clarity Pharmaceuticals Ltd
  • Koninklijke Philips N.V.
  • Thermo Fisher Scientific, Inc.
  • Telix Pharmaceuticals Limited
  • ABX advanced biochemical compounds GmbH

Global Theranostics Market Report Segmentation

By End User

  • Hospitals & Cancer Care Centers
  • Theranostics Centers
  • Research & Academic Centers

By Product

  • Radiopharmaceuticals
  • Diagnostic Imaging
  • IVD/Biomarker Screening
  • Software & Services

By Application

  • Prostate Cancer
  • Bone Metastasis
  • Other Cancers
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1Global Theranostics Market, by End User
    • 1.4.2Global Theranostics Market, by Product
    • 1.4.3Global Theranostics Market, by Application
    • 1.4.4Global Theranostics Market, by Geography
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Restraints
    • 3.2.3Market Opportunities
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.Global Theranostics Market by End User

  • 4.1Global Hospitals & Cancer Care Centers Market by Region
  • 4.2Global Theranostics Centers Market by Region
  • 4.3Global Research & Academic Centers Market by Region

Chapter 5.Global Theranostics Market by Product

  • 5.1Global Radiopharmaceuticals Market by Region
  • 5.2Global Diagnostic Imaging Market by Region
  • 5.3Global IVD/Biomarker Screening Market by Region
  • 5.4Global Software & Services Market by Region

Chapter 6.Global Theranostics Market by Application

  • 6.1Global Prostate Cancer Market by Region
  • 6.2Global Bone Metastasis Market by Region
  • 6.3Global Other Cancers Market by Region
  • 6.4Global Others Market by Region

Chapter 7.Global Theranostics Market by Region

  • 7.1North America Theranostics Market
    • 7.1.1North America Theranostics Market by End User
      • 7.1.1.1North America Hospitals & Cancer Care Centers Market by Country
      • 7.1.1.2North America Theranostics Centers Market by Country
      • 7.1.1.3North America Research & Academic Centers Market by Country
    • 7.1.2North America Theranostics Market by Product
      • 7.1.2.1North America Radiopharmaceuticals Market by Country
      • 7.1.2.2North America Diagnostic Imaging Market by Country
      • 7.1.2.3North America IVD/Biomarker Screening Market by Country
      • 7.1.2.4North America Software & Services Market by Country
    • 7.1.3North America Theranostics Market by Application
      • 7.1.3.1North America Prostate Cancer Market by Country
      • 7.1.3.2North America Bone Metastasis Market by Country
      • 7.1.3.3North America Other Cancers Market by Country
      • 7.1.3.4North America Others Market by Country
    • 7.1.4North America Theranostics Market by Country
      • 7.1.4.1US Theranostics Market
        • 7.1.4.1.1US Theranostics Market by End User
        • 7.1.4.1.2US Theranostics Market by Product
        • 7.1.4.1.3US Theranostics Market by Application
      • 7.1.4.2Canada Theranostics Market
        • 7.1.4.2.1Canada Theranostics Market by End User
        • 7.1.4.2.2Canada Theranostics Market by Product
        • 7.1.4.2.3Canada Theranostics Market by Application
      • 7.1.4.3Mexico Theranostics Market
        • 7.1.4.3.1Mexico Theranostics Market by End User
        • 7.1.4.3.2Mexico Theranostics Market by Product
        • 7.1.4.3.3Mexico Theranostics Market by Application
      • 7.1.4.4Rest of North America Theranostics Market
        • 7.1.4.4.1Rest of North America Theranostics Market by End User
        • 7.1.4.4.2Rest of North America Theranostics Market by Product
        • 7.1.4.4.3Rest of North America Theranostics Market by Application
  • 7.2Europe Theranostics Market
    • 7.2.1Europe Theranostics Market by End User
      • 7.2.1.1Europe Hospitals & Cancer Care Centers Market by Country
      • 7.2.1.2Europe Theranostics Centers Market by Country
      • 7.2.1.3Europe Research & Academic Centers Market by Country
    • 7.2.2Europe Theranostics Market by Product
      • 7.2.2.1Europe Radiopharmaceuticals Market by Country
      • 7.2.2.2Europe Diagnostic Imaging Market by Country
      • 7.2.2.3Europe IVD/Biomarker Screening Market by Country
      • 7.2.2.4Europe Software & Services Market by Country
    • 7.2.3Europe Theranostics Market by Application
      • 7.2.3.1Europe Prostate Cancer Market by Country
      • 7.2.3.2Europe Bone Metastasis Market by Country
      • 7.2.3.3Europe Other Cancers Market by Country
      • 7.2.3.4Europe Others Market by Country
    • 7.2.4Europe Theranostics Market by Country
      • 7.2.4.1Germany Theranostics Market
        • 7.2.4.1.1Germany Theranostics Market by End User
        • 7.2.4.1.2Germany Theranostics Market by Product
        • 7.2.4.1.3Germany Theranostics Market by Application
      • 7.2.4.2UK Theranostics Market
        • 7.2.4.2.1UK Theranostics Market by End User
        • 7.2.4.2.2UK Theranostics Market by Product
        • 7.2.4.2.3UK Theranostics Market by Application
      • 7.2.4.3France Theranostics Market
        • 7.2.4.3.1France Theranostics Market by End User
        • 7.2.4.3.2France Theranostics Market by Product
        • 7.2.4.3.3France Theranostics Market by Application
      • 7.2.4.4Russia Theranostics Market
        • 7.2.4.4.1Russia Theranostics Market by End User
        • 7.2.4.4.2Russia Theranostics Market by Product
        • 7.2.4.4.3Russia Theranostics Market by Application
      • 7.2.4.5Spain Theranostics Market
        • 7.2.4.5.1Spain Theranostics Market by End User
        • 7.2.4.5.2Spain Theranostics Market by Product
        • 7.2.4.5.3Spain Theranostics Market by Application
      • 7.2.4.6Italy Theranostics Market
        • 7.2.4.6.1Italy Theranostics Market by End User
        • 7.2.4.6.2Italy Theranostics Market by Product
        • 7.2.4.6.3Italy Theranostics Market by Application
      • 7.2.4.7Rest of Europe Theranostics Market
        • 7.2.4.7.1Rest of Europe Theranostics Market by End User
        • 7.2.4.7.2Rest of Europe Theranostics Market by Product
        • 7.2.4.7.3Rest of Europe Theranostics Market by Application
  • 7.3Asia Pacific Theranostics Market
    • 7.3.1Asia Pacific Theranostics Market by End User
      • 7.3.1.1Asia Pacific Hospitals & Cancer Care Centers Market by Country
      • 7.3.1.2Asia Pacific Theranostics Centers Market by Country
      • 7.3.1.3Asia Pacific Research & Academic Centers Market by Country
    • 7.3.2Asia Pacific Theranostics Market by Product
      • 7.3.2.1Asia Pacific Radiopharmaceuticals Market by Country
      • 7.3.2.2Asia Pacific Diagnostic Imaging Market by Country
      • 7.3.2.3Asia Pacific IVD/Biomarker Screening Market by Country
      • 7.3.2.4Asia Pacific Software & Services Market by Country
    • 7.3.3Asia Pacific Theranostics Market by Application
      • 7.3.3.1Asia Pacific Prostate Cancer Market by Country
      • 7.3.3.2Asia Pacific Bone Metastasis Market by Country
      • 7.3.3.3Asia Pacific Other Cancers Market by Country
      • 7.3.3.4Asia Pacific Others Market by Country
    • 7.3.4Asia Pacific Theranostics Market by Country
      • 7.3.4.1China Theranostics Market
        • 7.3.4.1.1China Theranostics Market by End User
        • 7.3.4.1.2China Theranostics Market by Product
        • 7.3.4.1.3China Theranostics Market by Application
      • 7.3.4.2Japan Theranostics Market
        • 7.3.4.2.1Japan Theranostics Market by End User
        • 7.3.4.2.2Japan Theranostics Market by Product
        • 7.3.4.2.3Japan Theranostics Market by Application
      • 7.3.4.3India Theranostics Market
        • 7.3.4.3.1India Theranostics Market by End User
        • 7.3.4.3.2India Theranostics Market by Product
        • 7.3.4.3.3India Theranostics Market by Application
      • 7.3.4.4South Korea Theranostics Market
        • 7.3.4.4.1South Korea Theranostics Market by End User
        • 7.3.4.4.2South Korea Theranostics Market by Product
        • 7.3.4.4.3South Korea Theranostics Market by Application
      • 7.3.4.5Singapore Theranostics Market
        • 7.3.4.5.1Singapore Theranostics Market by End User
        • 7.3.4.5.2Singapore Theranostics Market by Product
        • 7.3.4.5.3Singapore Theranostics Market by Application
      • 7.3.4.6Malaysia Theranostics Market
        • 7.3.4.6.1Malaysia Theranostics Market by End User
        • 7.3.4.6.2Malaysia Theranostics Market by Product
        • 7.3.4.6.3Malaysia Theranostics Market by Application
      • 7.3.4.7Rest of Asia Pacific Theranostics Market
        • 7.3.4.7.1Rest of Asia Pacific Theranostics Market by End User
        • 7.3.4.7.2Rest of Asia Pacific Theranostics Market by Product
        • 7.3.4.7.3Rest of Asia Pacific Theranostics Market by Application
  • 7.4LAMEA Theranostics Market
    • 7.4.1LAMEA Theranostics Market by End User
      • 7.4.1.1LAMEA Hospitals & Cancer Care Centers Market by Country
      • 7.4.1.2LAMEA Theranostics Centers Market by Country
      • 7.4.1.3LAMEA Research & Academic Centers Market by Country
    • 7.4.2LAMEA Theranostics Market by Product
      • 7.4.2.1LAMEA Radiopharmaceuticals Market by Country
      • 7.4.2.2LAMEA Diagnostic Imaging Market by Country
      • 7.4.2.3LAMEA IVD/Biomarker Screening Market by Country
      • 7.4.2.4LAMEA Software & Services Market by Country
    • 7.4.3LAMEA Theranostics Market by Application
      • 7.4.3.1LAMEA Prostate Cancer Market by Country
      • 7.4.3.2LAMEA Bone Metastasis Market by Country
      • 7.4.3.3LAMEA Other Cancers Market by Country
      • 7.4.3.4LAMEA Others Market by Country
    • 7.4.4LAMEA Theranostics Market by Country
      • 7.4.4.1Brazil Theranostics Market
        • 7.4.4.1.1Brazil Theranostics Market by End User
        • 7.4.4.1.2Brazil Theranostics Market by Product
        • 7.4.4.1.3Brazil Theranostics Market by Application
      • 7.4.4.2Argentina Theranostics Market
        • 7.4.4.2.1Argentina Theranostics Market by End User
        • 7.4.4.2.2Argentina Theranostics Market by Product
        • 7.4.4.2.3Argentina Theranostics Market by Application
      • 7.4.4.3UAE Theranostics Market
        • 7.4.4.3.1UAE Theranostics Market by End User
        • 7.4.4.3.2UAE Theranostics Market by Product
        • 7.4.4.3.3UAE Theranostics Market by Application
      • 7.4.4.4Saudi Arabia Theranostics Market
        • 7.4.4.4.1Saudi Arabia Theranostics Market by End User
        • 7.4.4.4.2Saudi Arabia Theranostics Market by Product
        • 7.4.4.4.3Saudi Arabia Theranostics Market by Application
      • 7.4.4.5South Africa Theranostics Market
        • 7.4.4.5.1South Africa Theranostics Market by End User
        • 7.4.4.5.2South Africa Theranostics Market by Product
        • 7.4.4.5.3South Africa Theranostics Market by Application
      • 7.4.4.6Nigeria Theranostics Market
        • 7.4.4.6.1Nigeria Theranostics Market by End User
        • 7.4.4.6.2Nigeria Theranostics Market by Product
        • 7.4.4.6.3Nigeria Theranostics Market by Application
      • 7.4.4.7Rest of LAMEA Theranostics Market
        • 7.4.4.7.1Rest of LAMEA Theranostics Market by End User
        • 7.4.4.7.2Rest of LAMEA Theranostics Market by Product
        • 7.4.4.7.3Rest of LAMEA Theranostics Market by Application

Chapter 8.Company Profiles

  • 8.1Bayer AG
    • 8.1.1Company Overview
    • 8.1.2Financial Analysis
    • 8.1.3Segmental and Regional Analysis
    • 8.1.4Research & Development Expense
    • 8.1.5Recent strategies and developments:
      • 8.1.5.1Acquisition and Mergers:
    • 8.1.6SWOT Analysis
  • 8.2GE HealthCare Technologies, Inc.
    • 8.2.1Company Overview
    • 8.2.2Financial Analysis
    • 8.2.3Segmental and Regional Analysis
    • 8.2.4Research & Development Expenses
    • 8.2.5Recent strategies and developments:
      • 8.2.5.1Partnerships, Collaborations, and Agreements:
    • 8.2.6SWOT Analysis
  • 8.3Siemens Healthineers AG (Siemens AG)
    • 8.3.1Company Overview
    • 8.3.2Financial Analysis
    • 8.3.3Segmental and Regional Analysis
    • 8.3.4Research & Development Expense
    • 8.3.5Recent strategies and developments:
      • 8.3.5.1Product Launches and Product Expansions:
    • 8.3.6SWOT Analysis
  • 8.4Cardinal Health, Inc.
    • 8.4.1Company Overview
    • 8.4.2Financial Analysis
    • 8.4.3Segmental and Regional Analysis
    • 8.4.4SWOT Analysis
  • 8.5Canon, Inc.
    • 8.5.1Company Overview
    • 8.5.2Financial Analysis
    • 8.5.3Segmental and Regional Analysis
    • 8.5.4Research & Development Expenses
    • 8.5.5SWOT Analysis
  • 8.6Clarity Pharmaceuticals Ltd
    • 8.6.1Company Overview
    • 8.6.2Financial Analysis
    • 8.6.3Research & Development Expenses
    • 8.6.4SWOT Analysis
  • 8.7Koninklijke Philips N.V.
    • 8.7.1Company Overview
    • 8.7.2Financial Analysis
    • 8.7.3Segmental and Regional Analysis
    • 8.7.4Research & Development Expense
    • 8.7.5SWOT Analysis
  • 8.8Thermo Fisher Scientific, Inc.
    • 8.8.1Company Overview
    • 8.8.2Financial Analysis
    • 8.8.3Segmental and Regional Analysis
    • 8.8.4Research & Development Expenses
    • 8.8.5SWOT Analysis
  • 8.9Telix Pharmaceuticals Limited
    • 8.9.1Company Overview
    • 8.9.2Financial Analysis
    • 8.9.3Segmental and Regional Analysis
    • 8.9.4Research & Development Expenses
    • 8.9.5SWOT Analysis
  • 8.10.ABX advanced biochemical compounds GmbH
    • 8.10.1Company Overview
    • 8.10.2SWOT Analysis

Chapter 9.Winning Imperatives of Theranostics Market